Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2807/1560-7917.ES.2021.26.28.2100563 http://scihub22266oqcxt.onion/10.2807/1560-7917.ES.2021.26.28.2100563 34269175!8284046!34269175     free     free     free       Euro+Surveill 2021 ; 26 (28): ? Nephropedia Template TP {{tp|p=34269175|t=2021. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 |pdf=|usr=}}{{34269175}} gab.com Text Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 JO: Euro Surveill http://www.kidney.de/pget.php?&tw=1&pmid=34269175 #FOAvip Evidence on COVID-19 vaccine efficacy/effectiveness (VE) in preventing asymptomatic SARS-CoV-2 infections is needed to guide public health recommendations for vaccinated people. We report interim results of a living systematic review. We identified a total of 30 studies that investigated VE against symptomatic and/or asymptomatic infection. In fully vaccinated individuals, VE against symptomatic and asymptomatic infections was 80-90% in nearly all studies. Fully vaccinated persons are less likely to become infected and contribute to transmission. Twit Text FOAVip Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 ????Euro Surveill http://www.kidney.de/pget.php?&tw=1&pmid=34269175 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34269175 #FOAvip English Wikipedia <ref>{{Cite pmid|34269175}}</ref> Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 #MMPMID34269175 Harder T; Koch J; Vygen-Bonnet S; Kulper-Schiek W; Pilic A; Reda S; Scholz S; Wichmann O Euro Surveill 2021[Jul]; 26 (28): ? PMID34269175show ga Evidence on COVID-19 vaccine efficacy/effectiveness (VE) in preventing asymptomatic SARS-CoV-2 infections is needed to guide public health recommendations for vaccinated people. We report interim results of a living systematic review. We identified a total of 30 studies that investigated VE against symptomatic and/or asymptomatic infection. In fully vaccinated individuals, VE against symptomatic and asymptomatic infections was 80-90% in nearly all studies. Fully vaccinated persons are less likely to become infected and contribute to transmission. |*COVID-19[MESH] |*COVID-19 Vaccines[MESH] |Asymptomatic Infections[MESH] |Humans[MESH]Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 inf(epmc).pdf DeepDyve Pubget Overpricing